Axsome Therapeutics

+$0.07 (+0.12%) Today
+$0.36 (+0.62%) As of 8:01 AM UTC after-hours

Why Robinhood?

You can buy or sell AXSM and other stocks, options, and ETFs commission-free!

About AXSM

Axsome Therapeutics, Inc. engages in the development of novel therapies for the management of central nervous system disorders. Its product candidates include AXS-05, AXS-07, AXS-12, and AXS-14 which are being developed for multiple pain and primary care indications.

CEO
Herriott Tabuteau
Employees
60
Headquarters
New York, New York
Founded
2012

AXSM Key Statistics

Market Cap
2.27B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
648.71K
High Today
$59.65
Low Today
$57.47
Open Price
$58.77
Volume
341.55K
52 Week High
$94.10
52 Week Low
$50.05

AXSM Earnings

-$0.88
-$0.59
-$0.29
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.87 per share
Actual
Available May 10, Pre-Market

You May Also Like

TRCA=
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure